Inclusion Criteria:  • Participated in, received treatment, and completed Protocol #06213  Exclusion Criteria:  Systemic disease that, in the opinion of the Investigator, would put the subject's health at risk and/or prevent completion of required study visits Ocular pathology which, in the Investigator's judgment, would either place the subject at increased risk of complications, contraindicate washout, place the subject at risk of significant vision loss during the study period (e.g., wet age macular degeneration (AMD), corneal edema, Fuch's dystrophy, active intraocular infection or inflammation within 30 days prior to Screening Visit, etc.), or interfere with compliance to elements of the study protocol (e.g., returning to Investigator's office for follow-up visits)